These 4 Indian Pharma Stocks will give good return between Tariff Trade War | Paisa Live


If your portfolio has Pharma stocks, then these news is very important for coming because there may be many big announcements. Us President Donald Trump is not taking the name of the Tariff. Trump applied 26% tariff rate on India but kept the Pharma Sector untouched but 8 April the Donald Trump itself announced the installation of tariffs on Pharmaceutical Companies and since which has been a tension in Pharma Companies. This tariff will affect both India and US countries. Indian pharma manufacturers earn from 30% to 50% from American Market. Let us talk about India’s 4 Indian Pharmaceutical Firms, whose stocks can be on high risk due to the tariff. So Dr Reddy’s Laboratories, Aurobindo Pharma, Zydus Lifescienes and Sun Pharma. Will it be right to buy these stocks during this Trade War, watch the video to know.



Source link

support@headlinenews360.com

Related Posts

American citizens will have to wear old clothes! Trump’s tariff caused havoc in fashion market

US-China Trade War: Donald Trump’s new tariff policy has shaken the fast fashion industry. The US is now ending the tax-free exemption on parcels less than $ 800 from China,…

Big change in gold-silver rate! Know what the expert said, the price will increase or the price will fall

Gold Price: This year gold made investors happy. In the domestic market, gold prices have been jumped by 23 per cent so far, while only 5 per cent has been…

Leave a Reply

Your email address will not be published. Required fields are marked *